Attached files
file | filename |
---|---|
EX-10.1 - EXHIBIT 10.1 - Neurotrope, Inc. | v453856_ex10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 21, 2016
NEUROTROPE, INC.
(Exact name of registrant as specified in its charter)
Nevada | 000-55275 | 46-3522381 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
205 East 42nd Street, 16th Floor
New York, New York 10017
(Address of principal executive offices, including ZIP code)
(973) 242-0005
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Effective on November 21, 2016, Neurotrope, Inc. (the “Company”) amended its 2013 Equity Incentive Plan, as amended (the “Plan”) pursuant to an Amendment to the Neurotrope, Inc. 2013 Equity Incentive Plan (the “Equity Incentive Plan Amendment”) to increase the number of shares of Common Stock available for issuance under the Plan to 21,930,300 shares of Common Stock. The foregoing description of the Equity Incentive Plan Amendment is qualified in its entirety by reference to the full text of the Equity Incentive Plan Amendment, a copy of which is being filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit No. |
Description | |
10.1 | Amendment to the Neurotrope, Inc. 2013 Equity Incentive Plan, dated November 21, 2016 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEUROTROPE, INC. | |||
Dated: November 23, 2016 | By: | /s/ Robert Weinstein | |
Name: | Robert Weinstein | ||
Title: | Chief Financial Officer, Executive Vice President, Secretary and Treasurer |
EXHIBIT INDEX
Exhibit No. |
Description | |
10.1 | Amendment to the Neurotrope, Inc. 2013 Equity Incentive Plan, dated November 21, 2016 |